Cibus Inc CBUS
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2017-07-20 |
| Shares Out. | 76,330,000 |
| Website | cibus.com/ ↗ |
| Phone | 18584500008 |
| Employees | 118 |
| Revenue | $1.7M |
| Gross Profit | $1.7M |
| Net Income | -$21.2M |
| Free Cash Flow | -$50.7M |
| Total Assets | $324.2M |
| Total Liabilities | $288.7M |
| Equity | $35.5M |
About Cibus Inc
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.
Cibus Inc is a publicly traded company under the ticker symbol CBUS on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
9 analysts (2026-07-01)